Topics

Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia

2014-08-27 03:12:10 | BioPortfolio

Summary

The primary objective of this study is to evaluate the safety and tolerability of repeated doses of RN316 in eligible healthy volunteers. RN316 is an investigational drug that is currently being studied as a cholesterol lowering therapy.

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Conditions

Hypercholesterolemia

Intervention

Placebo, 1 mg/kg every 2 weeks, 2 mg/kg every 4 weeks, 4 mg/kg every 4 weeks, 4 mg/kg every 8 weeks, 8 mg/kg every 8 weeks, 12 mg/kg every 8 weeks

Status

Not yet recruiting

Source

Pfizer

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:12:10-0400

Clinical Trials [519 Associated Clinical Trials listed on BioPortfolio]

MK0524A Clinical Efficacy Study

A study to determine lipid changing effects of MK0524A when compared to niacin extended release (NIASPAN) and placebo.

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease

This purpose of this study is to determine if the administration of ezetimibe and simvastatin together is more effective than simvastatin alone in lowering LDL-C levels to a goal of

A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received 4 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks

The primary objective of this study is to show that PFS (progress-free survival) rate at 6 months and at 1 year after randomization, of Nivolumab 480 mg every 4 weeks is non-inferior to ni...

MK0524A Phase IIb Study

Part A: This study will determine that MK0524 is well tolerated and does not effect lipids and blood glucose when given alone. Part B: Determine dose ranges for MK0524 and MK0524 plus Nia...

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis

To demonstrate the clinical effectiveness of MK0812 in the treatment of Arthritis.

PubMed Articles [4002 Associated PubMed Articles listed on BioPortfolio]

Long-term cognition and behavior in children born at early term gestation: a systematic review.

Recent recommendations characterize deliveries at 37 weeks 0 days through 38 weeks 6 days as early term. We aimed to systematically review the literature on long-term cognition, school performance, an...

Reduced exposure to piperaquine in young children, compared to adults, in children receiving dihydroartemisinin-piperaquine as malaria chemoprevention.

Dihydroartemisinin (DHA)-piperaquine is being evaluated as intermittent preventive therapy for malaria, but dosing has not been optimized for children. We assessed exposure to DHA and piperaquine in U...

Recovery from bradycardia and desaturation events at 32 weeks corrected age and NICU length of stay: an indicator of physiologic resilience?

Preterm very low birth weight (VLBW) infants experience physiologic maturation and transitions off therapies from 32 to 35 weeks postmenstrual age (PMA), which may impact episodic bradycardia and oxyg...

Subcutaneous Botulinum Toxin-A Injection for Treating Post-herpetic Neuralgia.

Postherpetic neuralgia (PHN) is a debilitating disease characterized by continuous, intense pain following an outbreak of herpes zoster. The pain associated with PHN can severely affect a patient's qu...

An indirect comparison of long-term efficacy of every-two-week dosing versus recommended dosing of ixekizumab in patients who had sPGA>1 at week 12.

Long-term efficacy and safety of ixekizumab (160 mg at Week 0, then 80 mg every 2 weeks [Q2W] for 12 weeks, followed by every 4 weeks [Q4W] thereafter [i.e., Q2W/Q4W], which is the labeled psoriasis d...

Medical and Biotech [MESH] Definitions

Number of fetal deaths with stated or presumed gestation of 20 weeks or more in a given population. Late fetal mortality is death after of 28 weeks or more.

A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks (294 days) after the first day of the last menstrual period (MENSTRUATION), or birth with gestational age of 41 weeks or more.

Documents or charts that show days, weeks, and months of a year.

A species of CORONAVIRUS causing a fatal disease to pigs under 3 weeks old.

Works about documents or charts that show days, weeks, and months of a year.

More From BioPortfolio on "Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia"

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Statins
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...


Searches Linking to this Trial